PATENT CLAIM ANALYSIS

Application Number: 16048611
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["558", "411000"]

Abstract:
Compounds of formula (I), wherein R 1  is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.

Claim (Index 28):
A method for the treatment of a disease or condition comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I, wherein R 1  is (C 2 -C 6 )alkenyl, or a pharmaceutical acceptable salt or ester thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 95.0
- Lexical Diversity: 1.20588
- Patent Class: 558.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14403023', '11995878', '11011887', '13002475', '13479045']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6616556457367829
- 35 USC 102 Novelty (BERT): 0.538338774149394
- Combined Prediction Score: 0.649323958578044
- Mean Citation Score: 198.954428
- Max Citation Score: 304.9714
- Similarity Product: 212.68090232424737

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test